Sign In

Alek Safarian

CEO at ALSA Ventures

Alek Safarian is the CEO of ALSA Ventures, a Europe based biotechnology investment firm specializing in novel therapeutics at early development stages. With a background as the founder and ex-CEO of Novotech, a prominent clinical CRO, Safarian brings extensive expertise to clinical asset development and active investment initiatives. ALSA Ventures operates without geographical or therapeutic limitations, engaging in activities ranging from seeding new companies to participating in later investment rounds.

Alek Safarian
Add to my network

Location

London, England, United Kingdom